PubMed Health⌕ Search

PubMed · 7708974

Differences in particle deposition between the two lungs.

Abstract

Certain inhalational diseases show a predilection for a particular region of one or the other lung that may be related to the site of deposition of inhaled particles. We conducted inhalation studies with monodispersed aerosol particles in 22 healthy student volunteers to determine how deposition varied between the two lungs. Ventilation lung scans were obtained with the subjects seated in front of a gamma camera while breathing radiolabelled particles. Subsequently we made paired comparisons of the radioactivity deposited in corresponding regions of the right and left lungs. Although regional differences in deposition between the left and right lung were often statistically significant, they were not always consistent between individuals. Particle deposition and the degree of penetration differed between the two lungs with there being generally more deposition in the perihilar region of the right lung. We suggest that the anatomy of the central airways may influence the pattern of deposition, thereby introducing disparities in particle deposition between the two lungs. The present findings lend support to experimental lung cast data and to the concept that anatomical differences between the two lungs influence the site of deposition.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Pityn, M J Chamberlain, M E King, W K Morgan. 1995. Differences in particle deposition between the two lungs.. https://doi.org/10.1016/0954-6111(95)90065-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.

In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis.

Administration, Inhalation↗

2. Advances in pharmacotherapy for COPD.

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.

Administration, Inhalation↗